Skip to content

qCON/qNOX-Guided Anesthesia to Prevent Emergence Agitation in Children: A Prospective Randomized Controlled Trial

Research on Preventing Pediatric Emergence Agitation through Dynamic Monitoring and Regulation of Analgesic Levels Based on qCON and qNOX.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111132
Enrollment
Unknown
Registered
2025-10-27
Start date
2025-10-30
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia

Interventions

Part 1: qNOX group (this group involves within-subjects pre- and post-stimulation comparison):Tetanic stimulations
X group from part 2:Standard monitoring was applied, with the depth of general anesthesia assessed using qCON and nociception monitored via qNOX.
C group from part 2 :Only standard monitoring was used.
N group from part 2:Standard monitoring was employed, and the depth of general anesthesia was assessed using Narcotrend.

Sponsors

Tianjin Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1.Children undergoing laparoscopic surgery; 2.Age 1-6 years old; 3.Weight 10-30Kg; 4.ASA I-II.

Exclusion criteria

Exclusion criteria: 1.Children under 1 year old and over 6 years old; 2.Suffering from contraindications for tracheal intubation such as laryngeal edema and acute laryngitis; 3.Suffering from mental system disorders such as epilepsy and cognitive impairment; 3.ASA >?; 5.The patient's family members do not agree.

Design outcomes

Primary

MeasureTime frame
Emergence agitation;The ability of the qNOX index to differentiate the degree of nociceptive stimulation.;

Secondary

MeasureTime frame
Opioid consumption;The dosage of sevoflurane;Time to remove the tracheal catheter;Emergence time;PACU stay time;Postoperative pain status;The occurrence of nausea, vomiting, and other adverse reactions.;Preoperative general status of the patient (age, sex, weight, ASA ) ;Remifentanil infusion rate;

Countries

China

Contacts

Public ContactWang Zhifen

Tianjin Children's Hospital

wzf9001@126.com+86 22 8778 7446

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026